Copyright
©The Author(s) 2025.
World J Gastrointest Pathophysiol. Dec 22, 2025; 16(4): 111306
Published online Dec 22, 2025. doi: 10.4291/wjgp.v16.i4.111306
Published online Dec 22, 2025. doi: 10.4291/wjgp.v16.i4.111306
Table 1 Complete metabolic panel showing elevated liver enzymes the following day after high-dose methylprednisolone
| Variable | Patient values | Normal range |
| AST | 224 | 15-41 U/L |
| Alkaline phosphatase | 111 | 32-91 U/L |
| Total bilirubin | 0.8 | 0.3-1.0 mg/dL |
| Calcium | 9.1 | 8.6-10.4 mg/dL |
| Total protein | 6.4 | 5.8-8.2 g/dL |
| Albumin | 4.0 | 3.5-5.1 g/dL |
| Glucose, blood | 211 | 70-139 mg/dL |
| BUN | 16 | 6-20 mg/dL |
| Creatinine | 0.60 | 0.44-1.03 mg/dL |
| BUN/creatinine ratio | 24.2 | 10.0-20.0 mgUN/mgCR |
| Sodium, blood | 141 | 136-145 mmol/L |
| Potassium, blood | 4.4 | 3.5-5.1 mmol/L |
| Chloride, blood | 107 | 98-107 mmol/L |
| Osmolality, calculated | 298 | 275-295 mOsm/kg |
| CO2 | 25 | 22-32 mmol/L |
| Anion gap | 9 | 4-15 mmol/L |
| ALT | 233 | 7-52 U/L |
| CKD-EPI eGFR | 100 | > 59 mL/minute/1.73 m2 |
Table 2 Naranjo adverse drug reaction probability scale for the patient
| Question | Yes | No | Do not know | Score |
| Are there previous conclusive reports on this reaction? | + 1 | 0 | 0 | + 1 |
| Did the adverse event appear after the suspected drug was administered? | + 2 | - 1 | 0 | + 2 |
| Did the adverse reaction improve when the drug was discontinued or a specific antagonist was administered? | + 1 | 0 | 0 | + 1 |
| Did the adverse reaction reappear when the drug was readministered? | + 2 | - 1 | 0 | 0 |
| Are there alternative causes (other than the drug) that could on their own have caused the reaction? | - 1 | + 2 | 0 | + 2 |
| Did the reaction reappear when a placebo was given? | - 1 | + 1 | 0 | 0 |
| Was the drug detected in the blood (or other fluids) in concentrations known to be toxic? | + 1 | 0 | 0 | 0 |
| Was the reaction more severe when the dose was increased or less severe when the dose was decreased? | + 1 | 0 | 0 | 0 |
| Did the patient have a similar reaction to the same or similar drugs in any previous exposure? | + 1 | 0 | 0 | 0 |
| Was the adverse event confirmed by any objective evidence? | + 1 | 0 | 0 | + 1 |
| Total score | 7 | |||
- Citation: English K. Drug-induced liver injury from high-dose intravenous methylprednisolone: A rare but known adverse effect. World J Gastrointest Pathophysiol 2025; 16(4): 111306
- URL: https://www.wjgnet.com/2150-5330/full/v16/i4/111306.htm
- DOI: https://dx.doi.org/10.4291/wjgp.v16.i4.111306
